Login to Your Account



Financings Roundup

Tensha Bags $15M Financing For Bromodomain Inhibitors

By Marie Powers


Tuesday, September 13, 2011
Tensha Therapeutics, a start-up developing small-molecule bromodomain inhibitors to treat cancer by regulating the transcription of disease-associated genes, has raised $15 million in a Series A financing from HealthCare Ventures LLC, of Boston.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription